Announcement
23 Oct 2026
: M42 and Inocras announce strategic collaboration to advance earlier detection of cancer recurrence in the UAE using whole genome powered MRD technology

Shaping the Future of Healthcare Through Clinical Education and Research

20 February 2025
Healthcare Innovations and Visionaries
Arab Health 2025

About the Speakers

  • Dr. Fernando Macário
    Group Chief Medical Officer, M42​
  • Dr. Vidya Velagapudi
    Senior Vice President, Precision Medicine and Academy of Education & Research, Global Patient Care platform, M42

  • Robert Adam Griffiths
    Director of Clinical Operations for Imperial College London Diabetes Centre
  • Alexander Gleason
    Director of Clinical Education for M42

    Watch Next